118 related articles for article (PubMed ID: 33500663)
1. GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer.
Huang Y; Liu Y; Zhu K; Ma X; Lu R; Zhang M
Cancer Manag Res; 2021; 13():499-508. PubMed ID: 33500663
[TBL] [Abstract][Full Text] [Related]
2. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
3. Effects and mechanisms of GSG2 in esophageal cancer progression.
Geng C; Wang Q; Xing PF; Wang M; Tong SD; Zhou JY
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3409-3421. PubMed ID: 35939116
[TBL] [Abstract][Full Text] [Related]
4. GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
Li L; Li S; Wang H; Li L; Wang P; Shen D; Dang X
Biochem Biophys Res Commun; 2022 Oct; 625():109-115. PubMed ID: 35952607
[TBL] [Abstract][Full Text] [Related]
5. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
Chen Y; Fu D; Zhao H; Cheng W; Xu F
Aging (Albany NY); 2020 May; 12(10):8858-8879. PubMed ID: 32439830
[TBL] [Abstract][Full Text] [Related]
6. Germ cell-specific gene 2 accelerates cell cycle in epithelial ovarian cancer by inhibiting GSK3α-p27 cascade.
Zhu K; Ma X; Guan X; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
J Mol Histol; 2024 Jun; 55(3):241-251. PubMed ID: 38613588
[TBL] [Abstract][Full Text] [Related]
7. Lncrna FGFR3-AS1 Is a Prognostic Indicator for Ovarian Cancer and Induces Cell Proliferation and Hinders Apoptosis.
Zhang Y; Sun L; Chen T; Yue Y; Zhao L; Zhang D
Iran J Public Health; 2023 Nov; 52(11):2412-2416. PubMed ID: 38106830
[TBL] [Abstract][Full Text] [Related]
8. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of
Yu W; Liu W; Feng Y; Zhu C
Genet Test Mol Biomarkers; 2022 Jan; 26(1):26-36. PubMed ID: 35089075
[No Abstract] [Full Text] [Related]
11. GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway.
Zhang F; Huang C
Aging (Albany NY); 2024 Mar; 16(6):5091-5107. PubMed ID: 38441546
[TBL] [Abstract][Full Text] [Related]
12. GSG2 promotes progression of human endometrial cancer by regulating PD-1/PD-L1 expression via PI3K-AKT pathway.
Chen H; Liu S; Wu S; Nong X; Liu N; Li L
Int Immunopharmacol; 2024 May; 134():112196. PubMed ID: 38759367
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic Analysis Reveals GSG2 as a Potential Target for Breast Cancer Therapy.
Ye Z; Zhang Z; Fang L; Tian D; Liu X
Open Life Sci; 2019 Jan; 14():688-698. PubMed ID: 33817208
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
15. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
16. HASPIN is involved in the progression of gallbladder carcinoma.
Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-dependent modulator of Gsg2/Haspin gene expression.
Sato S; Maeda C; Hattori N; Yagi S; Tanaka S; Shiota K
J Reprod Dev; 2011 Sep; 57(4):526-33. PubMed ID: 21606629
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
19. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis.
Ding L; Li B; Yu X; Li Z; Li X; Dang S; Lv Q; Wei J; Sun H; Chen H; Liu M; Li G
Cancer Cell Int; 2020; 20():125. PubMed ID: 32322172
[TBL] [Abstract][Full Text] [Related]
20. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
